1. Home
  2. OPK vs NBXG Comparison

OPK vs NBXG Comparison

Compare OPK & NBXG Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • OPK
  • NBXG
  • Stock Information
  • Founded
  • OPK 2007
  • NBXG 2021
  • Country
  • OPK United States
  • NBXG United States
  • Employees
  • OPK N/A
  • NBXG N/A
  • Industry
  • OPK Biotechnology: Pharmaceutical Preparations
  • NBXG Trusts Except Educational Religious and Charitable
  • Sector
  • OPK Health Care
  • NBXG Finance
  • Exchange
  • OPK Nasdaq
  • NBXG Nasdaq
  • Market Cap
  • OPK 1.0B
  • NBXG 1.1B
  • IPO Year
  • OPK 1995
  • NBXG N/A
  • Fundamental
  • Price
  • OPK $1.39
  • NBXG $15.21
  • Analyst Decision
  • OPK Buy
  • NBXG
  • Analyst Count
  • OPK 4
  • NBXG 0
  • Target Price
  • OPK $2.75
  • NBXG N/A
  • AVG Volume (30 Days)
  • OPK 1.9M
  • NBXG 243.7K
  • Earning Date
  • OPK 11-06-2025
  • NBXG 01-01-0001
  • Dividend Yield
  • OPK N/A
  • NBXG 10.25%
  • EPS Growth
  • OPK N/A
  • NBXG N/A
  • EPS
  • OPK N/A
  • NBXG N/A
  • Revenue
  • OPK $664,029,000.00
  • NBXG N/A
  • Revenue This Year
  • OPK N/A
  • NBXG N/A
  • Revenue Next Year
  • OPK $0.84
  • NBXG N/A
  • P/E Ratio
  • OPK N/A
  • NBXG N/A
  • Revenue Growth
  • OPK N/A
  • NBXG N/A
  • 52 Week Low
  • OPK $1.11
  • NBXG $9.31
  • 52 Week High
  • OPK $2.04
  • NBXG $12.23
  • Technical
  • Relative Strength Index (RSI)
  • OPK 51.88
  • NBXG 52.40
  • Support Level
  • OPK $1.34
  • NBXG N/A
  • Resistance Level
  • OPK $1.44
  • NBXG $15.24
  • Average True Range (ATR)
  • OPK 0.04
  • NBXG 0.15
  • MACD
  • OPK -0.00
  • NBXG -0.52
  • Stochastic Oscillator
  • OPK 50.00
  • NBXG 99.80

About OPK OPKO Health Inc.

OPKO Health Inc is a diversified biotechnology company that operates pharmaceutical and diagnostic development programs. Its segments include pharmaceutical and diagnostics. The Pharmaceutical segment consists of its pharmaceutical operations in Chile, Mexico, Ireland, Israel, Spain, Ecuador, France, the United States, and its pharmaceutical research and development operations. The Diagnostics segment consists of clinical and genomics laboratory operations through BioReference and point-of-care operations. It generates the majority of its revenue from the Diagnostics segment.

About NBXG Neuberger Berman Next Generation Connectivity Fund Inc.

Neuberger Berman Next Generation Connectivity Fund Inc. is a non-diversified, closed-end management investment company. The fund's investment objectives are to provide capital appreciation and income. Under normal market conditions, the Fund will invest at least 80% of its total assets in equity securities issued by U.S. and non-U.S. companies, in any market capitalization range, that is relevant to the theme of investing in "NextGen Companies".

Share on Social Networks: